Science Explorer Back to mapMap
Discussion
Researcher · Ospedale Vito Fazzi · Italy

Nicola Di Renzo

Nicola Di Renzo publishes mostly in Hematology, Genetics and Pathology and Forensic Medicine, on topics such as Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and Multiple Myeloma Research and Treatments.

ORCID 0000-0003-0604-6934 OpenAlex
World rank
#1,618,039
of 7,710,434 ranked researchers
Rank in Italy
#52,844
of 242,206
Works
314
Citations
6.2k
Citations per work
19.7
h-index
38
i10-index 102Top 7.1% in Hematology
Nicola Di Renzo

What does Nicola Di Renzo research?

Nicola Di Renzo's work is mostly in Medicine (58%), Biochemistry, Genetics and Molecular Biology (6%), Immunology and Microbiology (4%).

Health Sciences: 183 works · 58.4% of their workMedicine: 183 works · 58.4% of their workHematology: 61 works · 19.3% of their workGenetics: 51 works · 16.4% of their workPathology and Forensic Medicine: 38 works · 12.1% of their workOncology: 33 works · 10.6% of their workEverything else: 98 works · 31.2% of their workLife Sciences: 33 works · 10.4% of their workBiochemistry, Genetics and Molecular Biology: 19 works · 6.1% of their workMolecular Biology: 19 works · 6.1% of their workImmunology and Microbiology: 14 works · 4.3% of their workImmunology: 14 works · 4.3% of their workTHEIR WORKNicola Di Renzo314works
Life Sciences10%Health Sciences58%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine18358.4%
  2. Everything else9831.2%
    1. Biochemistry, Genetics and Molecular Biology196.1%
    2. Immunology and Microbiology144.3%
  1. 1Hematology19% of their works
  2. 2Genetics16% of their works
  3. 3Pathology and Forensic Medicine12% of their works
  4. 4Oncology11% of their works
  5. 5Molecular Biology6% of their works
  6. 6Immunology4% of their works

Research topics

Which keywords describe Nicola Di Renzo's research?

The keywords of their largest research topics: Rituximab, Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations, Classification, Lymphoma, Minimal Residual Disease and Prognostic Scoring System.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Rituximab2032 topics
  2. Prognostic Factors1773 topics
  3. Chronic Lymphocytic Leukemia1041 topic
  4. Genomic Aberrations1041 topic
  5. Classification991 topic
  6. Lymphoma991 topic
  7. Minimal Residual Disease762 topics
  8. Prognostic Scoring System512 topics
  9. Diagnosis Criteria491 topic
  10. International Myeloma Working Group491 topic
  11. AML461 topic
  12. Acute Myeloid Leukemia461 topic
  13. BCR-ABL451 topic
  14. Imatinib451 topic
  15. JAK2 Mutation281 topic
  16. Myelofibrosis281 topic
  17. Acute Lymphoblastic Leukemia271 topic
  18. Childhood Cancer271 topic
  19. Chemotherapy231 topic
  20. Primary CNS Lymphoma231 topic

Where does Nicola Di Renzo work?

Nicola Di Renzo's main affiliation in the publication record is Ospedale Vito Fazzi, Italy.

How many publications and citations does Nicola Di Renzo have?

OpenAlex counts 314 works and 6,184 citations for Nicola Di Renzo, an h-index of 38, ranking #1,618,039 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Nicola Di Renzo. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.